
Weight-loss medications may also benefit common medical problem, study finds
Fox News
Glucagon-like peptide-1 (GLP-1) agonists — weight loss medications widely used for type 2 diabetes and obesity — have been found to unexpectedly reduce alcohol consumption as a secondary benefit.
Among the regular drinkers, weekly alcohol intake decreased by 68%, from approximately 23 units of alcohol to around 8 units. "The findings in this study suggest that we may have just found a therapeutic target for alcohol use disorder."
The findings were recently published in the journal Diabetes, Obesity and Metabolism and were also presented last week at the European Congress on Obesity in Spain.

Pizza before tomatoes? Ancient Rome's version of America's favorite food looked nothing like today's
Ancient Rome pizza at Hungary restaurant features no tomatoes or mozzarella, using garum fish sauce and olive paste. Neverland Pizzeria's dish is limited-edition.












